MedTrace Logo

OcuStem Nutritional Supplement in Diabetic Patients With Mild to Moderate Non-proliferative Retinopathy

NCT02353923 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-08-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether supplementation with OcuStem, a nutritional supplement, will reduce the progression of mild to moderate diabetic retinopathy.

Conditions

Interventions

DIETARY_SUPPLEMENT

OcuStem Supplementation

2800 mg daily dosage of OcuStem, 2 capsules BID.

Sponsors & Collaborators

  • Aidan Products LLC

    lead INDUSTRY

Principal Investigators

  • Shalesh Kaushal, MD · Retina Specialty Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-05-31
Completion
2016-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02353923 on ClinicalTrials.gov